About the Product

Description


Domedrag DR Tablet containing Domperidone and Dexrabeprazole is used for the management of acid-related gastrointestinal disorders. It helps relieve symptoms associated with acid reflux, gastric discomfort, and digestive disturbances while supporting gastrointestinal health.

Dexrabeprazole works by reducing excess stomach acid production, while Domperidone helps improve gastric motility and supports faster stomach emptying. Together, they provide comprehensive gastroprotective and digestive support.

The tablet is widely prescribed in gastroenterology and general medicine practice for acid reflux disorders, gastritis, dyspepsia, and related gastrointestinal conditions, leading to consistent prescription demand.

With increasing prevalence of digestive disorders and growing demand for effective gastro care therapies, this product offers strong business potential for retailers and distributors. Its dual-action mechanism, broad clinical relevance, and steady market demand make it a reliable product for growth in the gastroenterology segment.

Some patients may experience headache, dry mouth, abdominal pain, diarrhea, constipation, dizziness, or nausea. Rarely, cardiac rhythm disturbances, allergic reactions, or significant electrolyte imbalances may occur and require immediate medical attention.

Domedrag DR Tablet is indicated for gastroesophageal reflux disease (GERD), acid reflux, heartburn, gastritis, dyspepsia, nausea associated with acid-peptic disorders, and other conditions requiring acid suppression and improved gastric motility. It helps relieve symptoms such as acidity, bloating, regurgitation, and upper abdominal discomfort.

This medicine should be used strictly under medical supervision. Long-term use should be undertaken only as advised by a healthcare professional. Use cautiously in patients with liver impairment, cardiac disorders, or those taking medicines that may affect heart rhythm. Follow the prescribed dosage and duration of treatment.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Domperidone 30mg + Dexrabeprazole 10mg Tablet in the PCD pharma franchise market?

Domperidone 30mg + Dexrabeprazole 10mg Tablet has strong demand in the gastroenterology, acidity management, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on digestive health portfolios.

Why should medical distributors include this combination in their product range?

Medical distributors and agencies can benefit from consistent demand for acid reflux and gastric disorder management under medical supervision. Dexrabeprazole 10mg is a proton pump inhibitor (PPI) that reduces stomach acid production Domperidone 30mg is a prokinetic agent that helps improve gastric emptying and reduces nausea Commonly prescribed for GERD (acid reflux), gastritis, indigestion, nausea, vomiting, and bloating Provides dual action: acid control + improved gastric motility Widely used by gastroenterologists and general physicians This strengthens a comprehensive gastroenterology and digestive care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Domperidone + Dexrabeprazole Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from high prescription demand in acidity and gastrointestinal disorders, repeat purchases, chronic therapy usage, reliable supply chain support, and attractive margins in the gastro segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional pharmaceutical support and a dependable supply chain for sustainable business growth.